
News|Articles|August 13, 2025
Demand-Led Clinical Supply Model for Program-level Product Pooling in Global Decentralized Study
Author(s)Catalent
Global decentralized trials require fast, efficient, and sustainable clinical supply solutions. This case study shows how a biopharma company worked with Catalent’s FastChain® demand-led model to improve supply by reducing waste and shipments by 40%, speeding patient dosing to under three weeks, and enabling flexible, decentralized packaging and distribution, whilst supporting an eco-friendly trial management worldwide.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
FDA Launches PreCheck Pilot Program to Bolster Domestic Drug Manufacturing
2
Cellares Scales IDMO Model for Gene-Edited Stem Cells Therapies
3
Women in STEM: Cultivating Scientific Confidence
4
Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D
5